XENE

XENE Operating Cash Flow (Statement)

-$337.52MTTM · USD

Period ending:

XENE FY Cash from OperationsUSD
XENE FY Cash from Operations2011-12-31: -$13.69M2012-12-31: $45.57M2013-12-31: -$3.32M2014-12-31: $266.00K2015-12-31: -$18.10M2016-12-31: -$19.57M2017-12-31: -$28.73M2018-12-31: -$34.72M2019-12-31: -$4.63M2020-12-31: -$48.12M2021-12-31: -$69.50M2022-12-31: -$98.43M2023-12-31: -$145.33M2024-12-31: -$181.39M2025-12-31: -$279.12M$45.57M-$279.12M
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

XENE operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Xenon Pharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-279,118,000
-181,389,000
-145,327,000
-98,430,000
-69,502,000
-48,124,000
-4,632,000
-34,724,000
-28,726,000
-19,567,000
-18,103,000
266,000
-3,322,000
45,573,000
-13,689,000

Compare operating cash flow (statement)

All XENE financial metrics · XENE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.